Name | APTEKA N 19, OOO |
---|
INN | 1105022010 |
---|
KPP | 110501001 |
---|
OGRN | 1121105000170 |
---|
OKPO | 16937453 |
---|
Address | 169600, Respublika Komi, g Pechora, ul Sotsialisticheskaya, d. D. 18 |
---|
Phone | +7 (912) 951-40-42 Contact details |
---|
Fax | 7-25-97 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | 47.75.1 | Additional activity | Retail sale of cosmetic and toilet articles in specialised stores | All types of activities | 47.75.2 | Additional activity | Retail drugstore products | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings | 77.29.9 | Additional activity | Rental of other household goods and personal items for households, businesses and organizations, not included in other categories |
Registration date | 01.03.2012 |
---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 2 po Respublike Komi |
---|
|
APTEKA N 19, OOO (Komi Republic; INN 1105022010) was registered on 1 Mar 2012. The company's authorized capital as of July 1, 2012 was 4527000 rub. Principal activities of APTEKA N 19, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retail sale of cosmetic and toilet articles in specialised stores (47.75.1). |
Economic indicators2022
Net profit (RAS) of APTEKA N 19, OOO dropped in 2022 60.00 times to 20.00 thousand RUB from 1.20 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 14.15% to 93.24 million RUB from 108.61 million RUB in 2021; cost of goods sold decreased by 14.65% to 67.10 million RUB from 78.61 million RUB; sales profit fell 2.44 times to 2.00 million RUB from 4.89 million RUB. 2021
Net profit (RAS) of APTEKA N 19, OOO dropped in 2021 by 23.76% to 1.20 million RUB from 1.57 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 1.01% to 108.61 million RUB from 107.52 million RUB over 2020; cost of goods sold grew by 1.21% to 78.61 million RUB from 77.67 million RUB; sales profit fell by 2.94% to 4.89 million RUB from 5.04 million RUB. 2020
Net profit (RAS) of APTEKA N 19, OOO grew over 2020 12.49 times to 1.57 million RUB from 126.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 9.10% to 107.52 million RUB from 98.55 million RUB over 2019; cost of goods sold grew by 10.61% to 77.67 million RUB from 70.22 million RUB; sales profit went up by 44.91% to 5.04 million RUB from 3.48 million RUB. 2019
Net profit (RAS) of APTEKA N 19, OOO dropped in 2019 15.02 times to 126.00 thousand RUB from 1.89 million RUB over the same period in 2018, the company informed. Revenue remained in the accounting period at the same level and made up 98.55 million RUB compared to 98.07 million RUB 98.07 million RUB; cost of goods sold grew by 0.60% to 70.22 million RUB from 69.80 million RUB; sales profit fell by 24.09% to 3.48 million RUB from 4.58 million RUB. 2018
Net profit (RAS) of APTEKA N 19, OOO dropped in 2018 by 6.52% to 1.89 million RUB from 2.02 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 2.03% to 98.07 million RUB from 100.11 million RUB in 2017; cost of goods sold decreased by 1.71% to 69.80 million RUB from 71.02 million RUB; sales profit went up by 7.76% to 4.58 million RUB from 4.25 million RUB. 2017
Net profit (RAS) of APTEKA 19, OOO dropped in 2017 2.50 times to 2.02 million RUB from 5.07 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 5.25% to 100.11 million RUB from 105.65 million RUB in 2016; cost of goods sold decreased by 5.74% to 71.02 million RUB from 75.35 million RUB; sales profit fell by 36.08% to 4.25 million RUB from 6.65 million RUB. 2016
Net profit (RAS) of APTEKA 19, OOO grew over 2016 2.00 times to 5.07 million RUB from 2.54 million RUB over 2015, the company informed. Revenue increased in the accounting period by 8.54% to 105.65 million RUB from 97.34 million RUB over 2015; cost of goods sold grew by 7.45% to 75.35 million RUB from 70.12 million RUB; sales profit went up 1.65 times to 6.65 million RUB from 4.02 million RUB. 2014
Net profit (RAS) of APTEKA 19, OOO dropped in 2014 by 5.86% to 4.78 million RUB from 5.07 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 14.33% to 99.17 million RUB from 86.73 million RUB over 2013; cost of goods sold grew by 14.13% to 70.98 million RUB from 62.19 million RUB; sales profit fell by 4.04% to 6.08 million RUB from 6.34 million RUB. 2013
Net profit (RAS) of APTEKA 19, OOO grew over 2013 by 42.71% to 5.07 million RUB from 3.55 million RUB over 2012, the company informed. Revenue increased in the accounting period by 33.90% to 86.73 million RUB from 64.77 million RUB over 2012; cost of goods sold grew by 33.34% to 62.19 million RUB from 46.64 million RUB; sales profit went up by 46.31% to 6.34 million RUB from 4.33 million RUB. 2012
Net profit (RAS) of Apteka 19, OOO grew over 2012 2.52 times to 3.55 million RUB from 1.41 million RUB over 2011, the company informed. Cost of goods sold remained at the same level amounting to 46.64 million RUB compared to 46.65 million RUB; sales profit went up 2.25 times to 4.33 million RUB from 1.93 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|